Tag: nasdaq:blue

July 22, 2019

What is Genetics Investing?

Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the most important life science...
July 18, 2019

5 Gene Therapy Stocks for Investors

What gene therapy companies should be on investors' radar? Here are five companies developing a wide range of gene therapy...
May 27, 2019

7 Largest Genetics Stocks by Market Cap

The genetics industry provides data that life science companies need to make new products. Here's a look at the largest genetics...
March 26, 2019

7 Potential Blockbuster Drugs Investors Should Watch for in 2019

A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
March 22, 2019

bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility

bluebird bio (NASDAQ:BLUE) has announced the opening of its first wholly owned manufacturing facility in Durham, North Carolina, which will...
October 16, 2018

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...
September 25, 2018

Investing in Stem Cell Treatments

Stem cell treatments have grabbed investor attention for years, but can be complex and potentially dangerous. Here is an overview...